Jiu’an Medical: Capacity expansion of kit products will not become a loss-making project

Securities Times e company news, on December 1, Jiu’an Medical Chairman and General Manager Liu Yi stated that the FDA requested the company to provide production capacity information during the company’s communication feedback during the application for the US FDA EUA. The company has estimated its production capacity based on its own equipment and labor resources. The US FDA has estimated the company’s monthly production capacity by the end of 2021 on its official website to be approximately 100 million people. 200 million copies of this information were publicized. Compared with electronic products, the capacity expansion of kit products has a short cycle and low investment, and will not become a loss-making project. (China Business News)